documents: FDA-2026-N-8163-0001

Federal regulatory documents currently open for public comment. ⚠ Derive comment deadlines from comment_end_datetime converted to America/New_York, never from comment_end_date, which is mid-correction and may be one day late (DataDawn queue #498).

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	agency_id	docket_id	title	document_type	subtype	posted_date	posted_year	posted_month	comment_start_date	comment_end_date	comment_end_datetime	perpetual_docket	last_modified	fr_doc_num	open_for_comment	withdrawn	object_id
FDA-2026-N-8163-0001	FDA	FDA-2026-N-8163	Reauthorization of the Prescription Drug User Fee Act; Public Meeting; Request for Comments	Notice	Request for Comments	2026-08-14	2026	8	2026-08-14	2026-10-16	2026-10-17 03:59:59	0	2026-10-15 09:00:26	2026-16650	1	0	09000064b94571b0